Welcome to the AHS 2020 ePoster Session. Please scroll down to view all of the submitted posters or press Control-F to search. To view the poster and its abstract, click on the poster image. Many posters also have a brief audio introduction which can be played by going to the bottom of the poster screen.
P017: REINFORCED BIOLOGIC MESH IN A MINIMALLY INVASIVE TECHNIQUE FOR VENTRAL HERNIA REPAIR
Cory J Banaschak, DO1; Kevin Benavente2; Paul Szotek, MD3; 1Ascension St. Vincent Hospital; 2Marian University College of Osteopathic Medicine; 3Indiana Hernia Center
Objective: To describe and evaluate the use of a reinforced biologic mesh in ventral hernia repair using the minimally invasive single incision retrorectus (SIRR) or single incision preperitoneal (SIPP) technique.
Methods: This study utilized a retrospective review of prospectively collected data from a single surgeon using a SIRR or SIPP technique for repair of ventral hernia between 2018-2019. All patients had varying sizes of either a primary or recurrent ventral hernia. Both techniques utilize a small incision (3cm), through which a wound protector (Alexis XS or S) or Gelport mini, for laparoscopic or robotic assistance, can be placed. The subcutaneous tissues are dissected laterally to define and reduce the ventral hernia. Once reduced, the preperitoneal space or retrorectus space is developed. In many cases, the endo-GIA stapler can be utilized to plicate the linea alba anteriorly and create a neo-posterior sheath posteriorly. A variant of a reinforced biologic mesh (Ovitex) was utilized in all cases either in the preperitoneal or retrorectus space. Follow-up was conducted through a HIPAA compliant application (Klara), in which, complications are self-reported by text messaging or phone call directly with the operative surgeon.
Results: From 2018-2019, 27 cases using either the SIRR or SIPP technique for a ventral hernia were identified. A majority of cases were open (n=25), and 2 cases were completed with robotic assistance. All cases utilized a variant of the reinforced biologic mesh. Most cases used the 20x20cm 1S variant. Length of follow-up varied from 141 to 564 days. Average follow-up was 335 days. There were no reported cases of recurrence. There was 1 reported surgical site occurrence (3.7%). This was a post-operative hematoma identified in a patient on chronic anticoagulation. There was also 1 death (3.7%) occurring on post-operative day 6. Exact cause of death is unknown, but does not appear to be directly related to the procedure. In conclusion, the use of a reinforced biologic mesh during the minimally invasive SIRR or SIPP procedure for ventral hernia appears to be an effective and safe option. A larger series with long term follow-up is being pursued.
Click the image below to expand: